PerkinElmer to Present Translating Data into Clinical Medicine at the Bio-IT World Conference
PerkinElmer to Present Translating Data into Clinical Medicine at the Bio-IT World Conference
WALTHAM, Mass.--(BUSINESS WIRE)-- PerkinElmer, Inc. (NYS: PKI) , a global leader focused on improving the health and safety of people and the environment, today announced that the Company will present at the Bio-IT World Conference at 11:00AM eastern time on Wednesday, April 10, 2013 at the Seaport World Trade Center located at 200 Seaport Boulevard in Boston, MA.
Kevin Hrusovsky, president of PerkinElmer's Life Sciences &Technology business, will be a featured speaker at the Bio-IT World Conference's Cancer Informatics track. In his Tools for Revolutionizing Translational Cancer Medicine presentation, Mr. Hrusovsky will discuss how combining the "in vitro-to-in vivo-to human" continuum of research tools with a powerful informatics platform may successfully bridge the chasm from laboratory research to clinical applications, particularly in the field of cancer medicine and personalized health.
For more information, visit the Bio-IT World Conference website.
About PerkinElmer
PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The company reported revenue of approximately $2.1 billion in 2012, has about 7,500 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.
Edelman (on behalf of PerkinElmer)
Paul Barren, 404-460-9679
Paul.barren@edelman.com
KEYWORDS: United States North America Massachusetts
INDUSTRY KEYWORDS:
The article PerkinElmer to Present Translating Data into Clinical Medicine at the Bio-IT World Conference originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
